Percutaneous Epicardial LAA Closure: When Does it Make Sense?

Similar documents
Devices to Protect Against Stroke in Atrial Fibrillation

Appendage Closure. Jason Rogers, MD. Director, Interventional Cardiology UC Davis Medical Center Sacramento, California

Role of cardiac imaging for catheterbased left atrial appendage closure

Left Atrial Appendage Occlusion in the Era of Novel Anticoagulants

Left Atrial Appendage Closure: The Rationale

SURGICAL VS ELECTROPHYSIOLOGICAL INTERVENTIONS FOR CARDIAC ARRHYTHMIAS DEBATE 2: LAA CLOSURE IS BEST DONE WITH DEVICES

LAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC

Update in Left Atrial Appendage Closure Devices. Faisal Al-Samadi MBBS, FRCPC, FACP, FACC, FSCAI, FHRS

Modern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update

ICE 2012 Ioannina,

Left atrial appendage occlusion

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device

Gauging stroke risk across the AF spectrum and selecting the appropriate patient for LAA closure. Miguel Valderrábano, MD

Left Atrial Appendage Closure: Moving Beyond Blood Thinners to Prevent Stroke in Atrial Fibrillation October 29, 2016

NCVH Birmingham 2013 August 24, Michael S. Bailey, MD Birmingham Heart Clinic

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke Saibal Kar, MD

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de

Left Atrial Appendage Occlusion

Left Atrial Appendage Closure Techniques: 2015

Trick or Treat 2: A New Era of Stroke Prevention in AF? WATCHMAN and LARIAT?

Update in Left Atrial Appendage Occlusion: More Options

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation

Left Atrial Appendage Closure Devices. Atrial Fibrillation 10/11/2017

Atrial fibrillation (AF), one of the

Europe. Other LAA occlusion devices are in clinical development.

Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation

Clinical Policy Bulletin: Cardiac Devices and Procedures for Occlusion of the Left Atrial Appendage

Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives

Devices for Stroke Prevention. Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP

Left Atrial Appendage Closure: The Good, The Bad and The Ugly

Left Atrial Appendage Closure: Techniques and Guidelines. Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA

Left Atrial Appendage Occlusion: Shutting Out Embolic Disease Without Anticoagulation

Recurrent Stroke under Anticoagulation in Mild MS & AF

Atrial fibrillation (AF) remains the most common

Clinical Data Summary & Discussion Of the Ultraseal Left Atrial Appendage (LAA) Closure Device

Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France

Left Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE

Left Atrial Appendage Closure for Stroke Prevention in Patients with Atrial Fibrillation

Disclosures 6/16/2015. Preventing Stroke in Atrial Fibrillation Warfarin Intolerance / Non-Compliance

EP Clinical Research Program Summary. Daniel L Lustgarten MD PhD Associate Professor The University of Vermont School of Medicine

Update in the Management of Atrial Fibrillation

Primary Care Atrial Fibrillation Update: Anticoagulation and Left Atrial Appendage Occlusion. Greg Francisco, MD, FACC

THINK OUTSIDE THE PILLBOX

Review Article Thromboembolism Prevention via Transcatheter Left Atrial Appendage Closure with Transeosophageal Echocardiography Guidance

Medical Policy Manual. Topic: Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation. Date of Origin: December 2011

Hands on workshops. 08:00-10:15 Session 1 - LAA morphology and imaging Moderator: Saibal Kar, MD / Shakeel A. Qureshi, MD / Bushra Rana, MD

MEDICAL POLICY SUBJECT: PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES EFFECTIVE DATE: 08/20/15 REVISED DATE: 10/20/16, 11/16/17

Exclusion de l auricule gauche par voie percutanée

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES DESCRIPTION. Page: 1 of 9

Commercial Products Percutaneous left atrial appendage closure is considered medically necessary when the criteria above is met.

Left Atrial Appendage Closure in SCRIPPS CLINIC

Invasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic

Left atrial appendage closure with the Amplatzer Cardiac Plug: Rationale for a higher degree of device oversizing at implantation

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

Which System Is better?: Watchman or Cardiac Plug or Something Else?

THINK OUTSIDE THE PILLBOX

Modern management of atrial fibrillation, from blood pressure control to anticoagulation

Rate or Rhythm Control? Epidemiology. Relevant Advances in Atrial Fibrillation 6/20/2011. Stroke Prophylaxis

Scientific Program of LAA 2014

Non-Pharmacologic Stroke Prevention For Atrial fibrillation: A Practical Review for the Practicing Cardiologist

Updates in Atrial Fibrillation

Atrial Fibrillation: Risk Stratification and Treatment New Cardiovascular Horizons St. Louis September 19, 2015

Cryptogenic Stroke: A logical approach to a common clinical problem

THINK OUTSIDE THE PILLBOX

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA

LAA and Stroke Prevention

Cardiac Devices Past, Present, and Future. Outline

Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Section Medicine

Left Atrial Appendage Closure 4 questions Who? When? How? Results?

Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation

Left Atrial Appendage Closure

Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Incomplete surgical ligation of the left atrial appendage time for a new look at an old problem

Relevant Advances in Atrial Fibrillation


ATRIAL SEPTAL CLOSURE AND LEFT ATRIAL APPENDAGE OCCLUSION: INDICATIONS AND GUIDANCE ECHOCARDIOGRAPHY IN INTERVENTIONAL CARDIOLOGY

Atrial fibrillation (AF) affects approximately 33 million

Five years of keeping a watch on the left atrial appendage how has the WATCHMAN fared?

Technique, Risk, and Benefit. T. Santoso University of Indonesia Medical School,

Managing the Left Atrial Appendage: Concepts & Controversies

More than 6 million people worldwide suffer from atrial

NEW APPROACHES AND NEW ANTICOAGULANTS FOR ATRIAL FIBRILLATION

ESC Congress 2012, Munich

Chapter 76 Left Atrial Appendage Closure: Indication and Technique

Safety and efficacy results in the EWOLUTION all-comers LAA closure study: DAPT subgroup

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Structural Heart Disease:" Innovations in Intervention!

Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke

European Journal of Cardio-Thoracic Surgery Advance Access published May 8, 2013

WATCHMAN: Where do we stand

Page 1. Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion. Atrial fibrillation: Scope of the problem

Atrial fibrillation and advanced age

LAmbre LAA Occluder Updates

Abstract 1 INTRODUCTION ORIGINAL ARTICLE

Show Me the Outcomes!

PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION:

The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?

Transcription:

Percutaneous Epicardial LAA Closure: When Does it Make Sense? Petr Neuzil, MD,PhD, FESC Professor of Medicine Cardiology department Na Homolce Hospital, Prague, Czechia petr.neuzil@gmail.com

Disclosures Grant support: Boston-Scientific Inc, Coherex /Biosense-Webster Inc, Sentreheart Inc Grant support / Consultant: St Jude Medical Inc

LAA Anatomy

Thrombus Formation (TEE)

Surgical LAA Exclusion LAA ligation or exclusion is regular part of mitral valve surgery. 1,2 Long term follow-up: Results of MAZE procedure 2 indicate significant reduction of strokes/tia in the case of concomitant LAA closure/exclusion Complete ligation is critical: Katz et al documeted during TEE incomplete LAA closure in 18/50 (36%) patients. 1 Authors indicate residual communication between LAA and rest of LA as increase risk for thromboembolic events. 1 1.Katz et al. Surgical LAA Ligation if Frequently Incomplete: A transesophageal Echocardiographic Study. J AM Coll Cardiol 2000;36:468-71. 2. Ad N, Cox JL.. Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000.

Surgical LAA Incomplete Closure

LAA clip occlusion device Atriclip Atricure: Self-closing implantable clip LAA closure regardless of LAA anatomy CT before and at 3-year follow-up after implantation Emmert MY at al: Eur J Cardio-Thorac Surg 2014,45:127.

LAA clip occlusion device Emmert MY at al: Eur J Cardio-Thorac Surg 2014,45:127.

Stroke Prophylaxis: Alternatives to Drugs Novel Anticoagulants Thrombin Inhibitors Dabigatran Factor Xa Inhibitors Apixaban Rivaroxaban Edoxaban LA Appendage Closure Surgical Epicardial Vascular PLAATO Amplatzer Cardiac Plug Wavecrest Watchman Blackshear and Odell, Ann Thoracic Surgery 1996

PLAATO LAA Occlusion Homolka Experience Watchman Amplatzer Cardiac Plug [ACP] WaveCrest Coherex Watchman Flex 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Watchman Gen 3 Lariat endo/epi Amplatzer Amulet

LAA Occlusion Homolka Experience 60 CHADS 2, Ø=2.79 Coherex; Lariat Total 239 implants 40 20 Amulet W 35% 0 60 0 1 2 3 4 5 6 CHA 2 DS 2 VASc, Ø= 3.84 ACP PLAATO M 65% 40 20 Watchman 0 0 1 2 3 4 5 6 7 8 9 Other Occluder Watchman 100 80 60 40 20 0 Age in time of procedure 2004 2015 Age < 37 Age > 89 Average 71.4 First half 68 Second half 74 Younger > 50 years 3 Registr OLAA NNH, 2015

PLAATO: Long-Term Outcomes 23 pts followed for 58 ± 9 mos Age: 68 ± 5 years CHADS 2 score: 3.6 ± 0.6 Hx CVA/TIA: All pts Long-Term follow-up: 58 ± 9 mos 2 deaths: cancer and CHF 4/23 (3.4%/yr) with CVA/TIA Time-to-event: 29.7 ± 10 mos All recovered w/o major sequelae CT/TEE: Leaks in 3/4 pts (75%) Do leaks predict strokes? LAA LEAK PLAATO With Stroke/ TIA Without Stroke/ TIA Age 61.8 ± 6.7 61.2 ± 5.7 CHADS 2 3.6 ± 0.6 3.5 ± 0.5 Leak? 3/4 (75%) 7/9 (78%) P.Neuzil & V.Reddy, JICE, 2012

Do peri-device leaks portend worse prognosis? Leak at 12mo in Primary Event Rate PROTECT AF (Events / 100 pt-yrs) cohort No Leak 67,9% 67.9% 2,5 2.5 Leak ( 5 mm) 32,1% 32.1% 2,1 2.1 J.Viles-Gonzales / V.Reddy, JACC

Epicardial LAA Ligation Electrocardiogram Guided Approach A B Friedman PA at al: J Cardiovasc Electrophysiol, 2009, 20: 909.

Stroke Prophylaxis: LAA Epicardial Exclusion Novel Anticoagulants Thrombin Inhibitors Dabigatran (RELY) Factor Xa Inhibitors Apixaban (AVERROES) Rivaroxaban (ROCKET AF) Sternum RV Liver LV LA Appendage Closure Surgical Epicardial Vascular PLAATO Amplatzer Cardiac Plug Wavecrest Watchman Modified from slide from: E Sosa, M Scanavacca, A d Avila

Lariat Epicardial LAA Ligation Components Bartus K at al: JACC 2013, 62:108-18.

Lariat Epicardial LAA Ligation Os Landmark Proximal LAA Closure

Lariat Epicardial LAA Ligation Melzer Knot Pre-confirm Control of Suture Atraumatic Suture Release

LAA Suture Ligation: Pre-Clinical Work Endocardial Balloon: Not Used Residual LAA Remnant: 3 / 4 (75%) S.Singh / A.d Avila / S.Dukkipati / V.Reddy, Heart Rhythm 2010

LAA Suture Ligation: Pre-Clinical Work Endocardial Balloon: Used Residual LAA Remnant: 0 / 5 (0%) S.Singh / A.d Avila / S.Dukkipati / V.Reddy, Heart Rhythm 2010

Clinical LAA Suture Ligation

Clinical LAA Suture Ligation

Clinical LAA Suture Ligation

Clinical LAA Suture Ligation Pre-Ligation Post-Ligation LAA

Lariat Incomplete LAA Suture Di Biase at al: Heart Rhythm 2014,11:1087-88.

LARIAT Epicardial LAA Ligation multicenter clinical experiences Study included 41 patients (4 centers) - LAA closure with the LARIAT system. RESULTS Ø age was 75 ± 10 years, Ø mean CHADS 2 score was 3.0 ± 1.3, Ø HAS-BLED score was 4.4 ± 1.4. Accumulated 24.6 person-years of follow-up. Acute LAA closure was achieved in 38 patients (93 %). 3.3 ± 0.8 m. after the procedure LAA leakage demonstrated by TEE or CT in 24 % pts. 1 pt (2 %) TIA, 8 (20 %) pericardial effusions requiring pericardiocentesis. 4 (9 %) were complicated by perforation of the LAA, with 2 of these patients requiring open surgical correction. Miller MA at al: Heart Rhythm 2014, 11:1853-59.

LARIAT Epicardial LAA Ligation multicenter clinical experiences Anticoagulation/Antiplatelet therapy pre and post Lariat Miller MA at al: Heart Rhythm 2014, 11:1853-59.

LARIAT Epicardial LAA Ligation first clinical experiences Single center non-randomized trial 85/89 (96%) patients IMPL/INCL 81 pts complete closure immediatelly 3 pts >2 mm residual leak 1 pt >3 mm residual leak At 1+3 months 81/85 + 77/81 (95%) complete closure After 1 year 65 (98%) complete closure included 1 with previous leak COMPLICATIONS: Access related 3, pericardial effussion 2 / late 1, SCD 2, late stroke 2 Bartus K at al: JACC 2013, 62:108-18.

LARIAT Epicardial LAA Ligation first clinical experiences Bartus K at al: JACC 2013, 62:108-18.

LARIAT Epicardial LAA Ligation first clinical experiences 3D CT reconstruction Bartus K at al: JACC 2013, 62:108-18.

LARIAT Epicardial LAA Ligation first clinical experiences Fluoroscopic guidance to assist in the closure of the LAA Bartus K at al: JACC 2013, 62:108-18.

LARIAT Epicardial LAA Ligation first clinical experiences Bartus K at al: JACC 2013, 62:108-18.

LARIAT Epicardial LAA Ligation first clinical experiences Pericardial access approach Bartus K at al: JACC 2013, 62:108-18.

LARIAT Epicardial LAA Ligation Intraoperative Multimodality Imaging TEE guidance of LARIAT balloon placement Laura DM at al: JASE 2014, 27:704.

LARIAT Epicardial LAA Ligation Intraoperative Multimodality Imaging Fluoroscopy guidance of wires connection and snare placement Laura DM at al: JASE 2014, 27:704.

? Price M J at al: JACC 2014, 64: 569.

FINAL THOUGHTS 1. Epicardial LAA exclusion is more independent on its anatomy 2. There is no any device implanted 3. Stop anticoagulation after procedure 4. Less thrombogenic 5. Permanent occlusion?

Computed tomography findings at twelve-, twenty-, and thirty-six month follow-up after LAA clip surgery Emmert MY at al: LAA clip occlusion device. Eur J Cardio-Thorac Surg 2014,45:129.

Adverse events after LAA closure using the LARIAT device Miller MA at al: Safety of LAA closure with the LARIAT device. Heart Rhythm 2014, 11:1856.

Percutaneous Appendage Closure. Background: Pharmacologic therapies to prevent stroke in atrial fibrillation (AF) have numerous limitations, prompting the development of device-based therapies. We investigated whether an electrogram-based approach using a novel hollow suture can safely capture and ligate the left atrial appendage (LAA). Methods and Results: A novel system for closure of the LAA within the confines of the closed pericardium with a single sheath puncture was tested in 4 dogs. The tool used to grasp the appendage was fitted with electrodes and utilized electrical navigation to identify and confirmlaacapture. Ahollowsuture preloaded with a mechanical support wire to permit its manipulation and fluoroscopic visualization was advanced over the grasper, and the wire removed after the suture was positioned. The LAA was successfully closed in all dogs. In 2 dogs, after closure, a thoracotomy was performed and the LAA amputated without bleeding, confirming closure integrity. Necropsy confirmed closure in all animals. Conclusions: Using electrical navigation, percutaneous epicardial LAA ligation with a remotely tightened suture was performed successfully within the confines of the intact pericardial space. This technique may allow decreasing the risk of stroke in AF patients without the need for thoracotomy or an endocardially placed prosthetic device. left atrial appendage, atrial fibrillation, stroke, epicardial, electrograms Friedman PA at al.:percutaneous appendage closure. J Cardiovasc Electrophysiol, 2009,, 20, :908-915.

Necropsy evaluation of left atrial appendage (LAA closure) Friedman PA at al: Percutaneous appendage closure. J Cardiovasc Electrophysiol, 2009, 20: 913.